• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Strata Critical Medical Inc.

    4/14/26 8:55:51 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary
    Get the next $SRTA alert in real time by email
    DEFA14A 1 ny20060135x2_defa14a.htm DEFA14A
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 14A
     
    Proxy Statement Pursuant to Section 14(a) of the
    Securities Exchange Act of 1934 (Amendment No.  )
    Filed by the Registrant ☒
    Filed by a Party other than the Registrant  ☐
    Check the appropriate box:
     ☐
    Preliminary Proxy Statement
     ☐
    Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
     ☐
    Definitive Proxy Statement
    ☒
    Definitive Additional Materials
     ☐
    Soliciting Material Pursuant to §240.14a-12
     
    Strata Critical Medical, Inc
    (Name of Registrant as Specified In Its Charter)
     
     
    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)
     
    Payment of Filing Fee (Check the appropriate box):
    ☒
    No fee required.
     ☐
    Fee paid previously with preliminary materials.
     ☐
    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11.



     Your Vote Counts!  Smartphone users  Point your camera here and vote without entering a control number  For complete information and to vote, visit www.ProxyVote.com  Control #  QAARV1-P12345  You invested in STRATA CRITICAL MEDICAL, INC. and it's time to vote!  You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the shareholder meeting to be held on May 28, 2026.  Get informed before you vote  View the Notice & Proxy Statement, Annual Report on Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 14, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.  Ricky Campana  P.O. Box 123456  Suite 500  51 Mercedes Way  Edgewood, NY 11717  1 OF  322,224  148,294  4  30#  XXXX XXXX XXXX XXXX  V2.1  STRATA CRITICAL MEDICAL, INC.  2026 Annual Meeting  Vote by May 27, 2026  11:59 PM ET  STRATA CRITICAL MEDICAL, INC. 666 THIRD AVENUE, 25TH FLOOR NEW YORK, NEW YORK 10017  Vote Virtually at the Meeting*  May 28, 2026  9:00 AM EDT  Virtually at:  www.virtualshareholdermeeting.com/SRTA2026  *Please check the meeting materials for any special requirements for meeting attendance. 
     


     THIS IS NOT A VOTABLE BALLOT  This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters.  Vote at www.ProxyVote.com  Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”.  QAARV2-P12345  Elect Class II Directors for terms expiring in 2029.  Nominees:  William A. Heyburn 02) Andrew Lauck  For  2. Ratify Appointment of Independent Registered Public Accounting Firm for 2026 (Deloitte & Touche LLP).  For  3. Advisory Vote on the Compensation of our Named Executive Officers.  For  NOTE: Such other business as may properly come before the meeting or any adjournment thereof.  Voting Items  Board Recommends  Control # XXXX XXXX XXXX XXXX  SHARE CLASSES REPRESENTED FOR VOTING  THE COMPANY NAME INC. - COMMON ASDFGHJKL 123456789.1234  THE COMPANY NAME INC. - CLASS A  123456789.1234  THE COMPANY NAME INC. - CLASS B  123456789.1234  THE COMPANY NAME INC. - CLASS C  123456789.1234  THE COMPANY NAME INC. - CLASS D  123456789.1234  THE COMPANY NAME INC. - CLASS E  123456789.1234  THE COMPANY NAME INC. - CLASS F  123456789.1234  THE COMPANY NAME INC. - 401 K  123456789.1234  1.00000  322,224  148,294  CLT ID 
     
    Get the next $SRTA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SRTA

    DatePrice TargetRatingAnalyst
    3/25/2026$8.00Buy
    Craig Hallum
    3/25/2026$8.00Buy
    B. Riley Securities
    12/2/2025$8.00Buy
    Lake Street
    More analyst ratings

    $SRTA
    SEC Filings

    View All

    SEC Form DEFA14A filed by Strata Critical Medical Inc.

    DEFA14A - Strata Critical Medical, Inc. (0001779128) (Filer)

    4/14/26 8:55:51 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    SEC Form DEF 14A filed by Strata Critical Medical Inc.

    DEF 14A - Strata Critical Medical, Inc. (0001779128) (Filer)

    4/14/26 8:54:09 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    SEC Form 10-K filed by Strata Critical Medical Inc.

    10-K - Strata Critical Medical, Inc. (0001779128) (Filer)

    3/3/26 11:52:26 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    $SRTA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference

    NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), today announced that management will present at the 25th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2026, at 1:30 pm ET. A webcast of the event will be available at the link here. A replay will be available shortly after the conclusion of the presentation on the investor relations section of the Company's website at https://ir.stratacritical.com/. About Strata Critical Medical Strata Critical Medical provides time-critical logistics solutions and specialized medical services to healthcare providers across the United States, strategically expandi

    4/9/26 5:11:28 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Strata Critical Medical Announces Fourth Quarter 2025 Results

    Revenue increased 83.5% year-over-year to $66.8 million in Q4 2025Logistics revenue and gross profit grew 35.3% and 39.5% year-over-year, respectively, in Q4 2025, which represents Strata's organic growthFull year 2025 net loss from continuing operations was $20.1 millionFull year 2025 revenue and Adjusted EBITDA(1) of $197.1 million and $14.1 million, respectively, both beat the high end of our guidance rangeRaising full year 2026 revenue guidance to between $260 and $275 million and Adjusted EBITDA guidance to between $29 and $33 million(2) NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, ", Strata", or the ", Company", )), today announced financi

    3/3/26 7:00:00 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Strata Critical Medical Schedules Fourth Quarter 2025 Earnings Conference Call

    NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical (NASDAQ:SRTA, "Strata" or the "Company")), will release financial results for the fourth quarter ended December 31, 2025 on Tuesday, March 3, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Will Heyburn, Strata's Co-Chief Executive Officer and Chief Financial Officer, and Melissa Tomkiel, Strata's Co-Chief Executive Officer and General Counsel, and will include a question-and-answer session for call participants. To join the live call, please register here. Upon registration, a dial-in and unique PIN will be pr

    2/10/26 4:00:00 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    $SRTA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Craig Hallum initiated coverage on Strata Critical Medical with a new price target

    Craig Hallum initiated coverage of Strata Critical Medical with a rating of Buy and set a new price target of $8.00

    3/25/26 8:36:47 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    B. Riley Securities initiated coverage on Strata Critical Medical with a new price target

    B. Riley Securities initiated coverage of Strata Critical Medical with a rating of Buy and set a new price target of $8.00

    3/25/26 8:35:45 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Lake Street resumed coverage on Strata Critical Medical with a new price target

    Lake Street resumed coverage of Strata Critical Medical with a rating of Buy and set a new price target of $8.00

    12/2/25 8:39:50 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    $SRTA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-CEO and CFO Heyburn William A. bought $76,044 worth of shares (17,000 units at $4.47), increasing direct ownership by 1% to 1,403,436 units (SEC Form 4)

    4 - Strata Critical Medical, Inc. (0001779128) (Issuer)

    12/10/25 4:15:25 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Director Lauck Andrew bought $21,825 worth of shares (5,000 units at $4.37), increasing direct ownership by 4% to 135,642 units (SEC Form 4)

    4 - Strata Critical Medical, Inc. (0001779128) (Issuer)

    12/5/25 4:21:01 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    $SRTA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4 filed by Cohen Amir

    4/A - Strata Critical Medical, Inc. (0001779128) (Issuer)

    3/23/26 4:02:27 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    SEC Form 4 filed by Wunsch Scott M

    4 - Strata Critical Medical, Inc. (0001779128) (Issuer)

    3/18/26 4:02:18 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    SEC Form 4 filed by Strata Critical Medical Inc.

    4 - Strata Critical Medical, Inc. (0001779128) (Issuer)

    3/10/26 5:28:46 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    $SRTA
    Leadership Updates

    Live Leadership Updates

    View All

    Strata Critical Medical, Inc. Appoints Will Cook to Board of Directors

    NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Board of Directors (the "Board") of Strata Critical Medical, Inc. ("Strata" or the "Company"), a leading provider of logistics and medical services in the organ transplant industry, today announced the appointment of Will Cook to the Board, effective December 3, 2025. Mr. Cook has also been appointed to the Compensation and Nominating and Corporate Governance Committees. Mr. Cook is the President and Chief Executive Officer of Vail Health, a nonprofit community health care system headquartered in Vail, Colorado. "We are very excited to welcome Will Cook to our board of directors," said Melissa Tomkiel, Strata's Co-Chief Executive Office

    12/3/25 5:00:00 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    $SRTA
    Financials

    Live finance-specific insights

    View All

    Strata Critical Medical Announces Fourth Quarter 2025 Results

    Revenue increased 83.5% year-over-year to $66.8 million in Q4 2025Logistics revenue and gross profit grew 35.3% and 39.5% year-over-year, respectively, in Q4 2025, which represents Strata's organic growthFull year 2025 net loss from continuing operations was $20.1 millionFull year 2025 revenue and Adjusted EBITDA(1) of $197.1 million and $14.1 million, respectively, both beat the high end of our guidance rangeRaising full year 2026 revenue guidance to between $260 and $275 million and Adjusted EBITDA guidance to between $29 and $33 million(2) NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, ", Strata", or the ", Company", )), today announced financi

    3/3/26 7:00:00 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Strata Critical Medical Schedules Fourth Quarter 2025 Earnings Conference Call

    NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical (NASDAQ:SRTA, "Strata" or the "Company")), will release financial results for the fourth quarter ended December 31, 2025 on Tuesday, March 3, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Will Heyburn, Strata's Co-Chief Executive Officer and Chief Financial Officer, and Melissa Tomkiel, Strata's Co-Chief Executive Officer and General Counsel, and will include a question-and-answer session for call participants. To join the live call, please register here. Upon registration, a dial-in and unique PIN will be pr

    2/10/26 4:00:00 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Strata Critical Medical Announces Third Quarter 2025 Results

    Revenue increased 36.7% year-over-year to $49.3 million in Q3 2025 and grew 29.0% excluding the impact of the Keystone acquisition Net loss increased to $(9.7) million in Q3 2025 versus $(5.6) million in the prior year periodMedical Segment Adjusted EBITDA increased 93.5% in Q3 2025 to $7.6 million versus the prior year period and increased 80.2% excluding the impact of the Keystone acquisition(1)Medical Segment Adjusted EBITDA margin excluding Keystone increased to 15.1% in Q3 2025(1)Raised 2025 revenue guidance to $185-195 million, reaffirmed Adjusted EBITDA rangeInvestor Day scheduled for November 17th 2025; will introduce 2026 guidance and medium term financial targets NEW YORK, Nov. 1

    11/10/25 7:00:00 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary